Article
T cell correction pipeline for Inborn Errors of Immunity
2024-09-06
Abstract excerpt
CRISPR/Cas9 gene editing technology is a promising tool for correcting pathogenic variants for autologous cell therapies for Inborn Errors of Immunity (IEI). The present IEI correction strategies mainly focus on the knock-in of therapeutic cDNAs, or knockout of the disease-causing gene when feasible. These strategies address many single-gene defects but may disrupt gene expression and require significant optimizat...
Topics
Open a Topic to create a Post that cites this publication.
Identifiers and source
- Literature Corpus work
- a7c467be-9484-5ae4-978c-7f68dd48bc22
- DOI
- 10.1101/2024.09.03.610811
